Drug points: Rapidly reversible increase in insulin requirement with interferon
| Autor: | Booth J. Danesh, S. Campbell, E H Mclaren |
|---|---|
| Rok vydání: | 1996 |
| Předmět: |
Hepatitis
medicine.medical_specialty business.industry Insulin medicine.medical_treatment General Engineering Alpha interferon General Medicine Hepatitis C medicine.disease chemistry.chemical_compound Endocrinology chemistry Interferon Internal medicine Diabetes mellitus medicine Spironolactone General Earth and Planetary Sciences Glycosylated haemoglobin business General Environmental Science medicine.drug |
| Zdroj: | BMJ. 313:92-92 |
| ISSN: | 1468-5833 0959-8138 |
| DOI: | 10.1136/bmj.313.7049.92a |
| Popis: | We report a case of a 66 year old man with maturity onset diabetes who developed a rapidly reversible increase in insulin requirement while receiving interferon alfa 2a for hepatitis C. The patient's diabetes had been well controlled for three years on a total of 62 units of Mixtard daily (glycosylated haemoglobin 7-9%). His other medications were spironolactone 100 mg twice daily and bumetanide 1 mg daily. After … |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|